PURE has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PURE has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, PURE Bioscience's Trailing 12-Month Free Cash Flow is $-2.26 Mil, and Market Cap is $10.64 Mil. Therefore, PURE Bioscience's FCF Yield % for today is -21.19%.
The historical rank and industry rank for PURE Bioscience's FCF Yield % or its related term are showing as below:
During the past 13 years, the highest FCF Yield % of PURE Bioscience was 1.56%. The lowest was -40.32%. And the median was -10.09%.
PURE Bioscience's FCF Margin % for the quarter that ended in Jan. 2025 was -139.13%.
The historical data trend for PURE Bioscience's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PURE Bioscience Annual Data | |||||||||||||||||||||
Trend | Jul15 | Jul16 | Jul17 | Jul18 | Jul19 | Jul20 | Jul21 | Jul22 | Jul23 | Jul24 | |||||||||||
FCF Yield % | Get a 7-Day Free Trial |
![]() |
![]() |
0.49 | -4.61 | -11.24 | -34.82 | -28.36 |
PURE Bioscience Quarterly Data | ||||||||||||||||||||
Apr20 | Jul20 | Oct20 | Jan21 | Apr21 | Jul21 | Oct21 | Jan22 | Apr22 | Jul22 | Oct22 | Jan23 | Apr23 | Jul23 | Oct23 | Jan24 | Apr24 | Jul24 | Oct24 | Jan25 | |
FCF Yield % | Get a 7-Day Free Trial |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
-28.45 | -30.98 | -26.57 | -19.14 | -27.02 |
For the Household & Personal Products subindustry, PURE Bioscience's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Consumer Packaged Goods industry and Consumer Defensive sector, PURE Bioscience's FCF Yield % distribution charts can be found below:
* The bar in red indicates where PURE Bioscience's FCF Yield % falls into.
FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
PURE Bioscience's FCF Yield % for the fiscal year that ended in Jul. 2024 is calculated as
FCF Yield % | = | Free Cash Flow | / | Market Cap |
= | -2.531 | / | 8.9261088 | |
= | -28.36% |
PURE Bioscience's annualized FCF Yield % for the quarter that ended in Jan. 2025 is calculated as
FCF Yield % | = | Free Cash Flow | * | Annualized Factor | / | Market Cap |
= | -0.544 | * | 4 | / | 8.053632 | |
= | -27.02% |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PURE Bioscience FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Thank you for viewing the detailed overview of PURE Bioscience's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.
Robert F Bartlett | director | 9669 HERMOSA AVENUE, RANCHO CUCAMONGA CA 91730 |
Bernard Blotner | director | 9669 HERMOSA AVENUE, RANCHO CUCAMONGA CA 91730 |
Tom Y Lee | director | 1807 SAN GABRIEL BLVD., SAN GABRIEL CA 91776 |
David Rendall | director | 9669 HERMOSA AVENUE, RANCHO CUCAMONGA CA 91730 |
Kristin Taylor | director | 13500 EVENING CREEK DRIVE N, SUITE 550, SAN DIEGO CA 92128 |
Dale Okuno | director | 35 N. ARROYO PARKWAY, SUITE 1, PASADENA CA 91103 |
Ivan Chen | director | 1725 GILLESPIE WAY, EL CAJON CA 92020 |
Thomas Richard Myers | officer: Chief Operating Officer | 1725 GILLESPIE WAY, EL CAJON CA 92130 |
Henry R. Lambert | director, officer: Chief Executive Officer | 1725 GILLESPIE WAY, EL CAJON CA 92020 |
Elisabeth Hagen | director | 1725 GILLESPIE WAY, EL CAJON CA 92020 |
Janet Risi Field | director | 9200 SOUTH DADELAND BOULEVARD, SUITE 800, MIAMI FL 33156 |
Franchise Brands, Llc | 10 percent owner | 325 BIC DRIVE, MILFORD CT 06461 |
Mark Stuart Elliott | officer: Vice President, Finance | 1725 GILLESPIE WAY, EL CAJON CA 92020 |
William Otis | director | 1725 GILLESPIE WAY, EL CAJON CA 92020 |
David M Theno | director | 1725 GILLESPIE WAY, EL CAJON CA 92020 |
From GuruFocus
By gurufocus • 12-15-2008
By GuruFocus Research • 02-14-2024
By GuruFocus Research GuruFocus Editor • 06-30-2010
By PRNewswire PRNewswire • 11-02-2022
By [email protected] insider • 06-23-2020
By GuruFocus Research • 02-14-2024
By [email protected] insider • 06-18-2020
By GuruFocus News • 12-19-2024
By gurufocus 10qk • 03-17-2011
By GuruFocus Research GuruFocus Editor • 12-28-2020
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.